US ban of China Telecom may affect its international partners and customers

MANILA, Dec. 16, 2021 (GLOBE NEWSWIRE) — Philippine legislator and House of Representatives Assistant Minority Leader France Castro has warned that the U.S. Federal Communications Commission’s (FCC) decision to ban China Telecom will affect the ability of its partners and affiliates around the world, such as Dito Telecommunity in the Philippines, to operate and serve its customers effectively given the tightening restrictions against its principal.

Due to national security concerns, the FCC adopted last October 26 an Order on Revocation and Termination, which directs China Telecom Americas to discontinue any domestic or international services it provides in the U.S. within 60 days of the order’s release.

The FCC determined that China Telecom “is subject to exploitation, influence, and control by the Chinese government”. Such control may allow China “to access, store, disrupt, and/or misroute U.S. communications.”

According to Castro, China Telecom’s US ban may have negative effects on the Philippines’ Dito Telecommunity – a telco that is 40% owned by China Telecom.

She explained that the termination of the China Telecom U.S. operations may prevent Dito from executing inter-connection activities in the U.S., such as roaming services for Filipino subscribers who need to make calls or send messages while overseas. Calls from Filipinos to their families or contacts in the U.S. through Dito may also be hindered.

Philippine lawmakers belonging to the House Committee on Information and Communications Technology are also monitoring the recent FCC order against China Telecom, given the Philippines’ own national security concerns about China.

Dito Telecommunity’s entry into the Philippine market earlier this year had already been marred by concerns about national security.

An industry report, entitled “A Study Into The Proposed New Telecommunications Operator In The Philippines: Critical Success Factors and Likely Risks”, and undertaken by Asia-Pacific consulting firm CreatorTech, had in fact described China Telecom as a fully-controlled entity of the Government of the People’s Republic of China (PRC). Its immediate reporting line is to China’s Ministry of Industry and Information Technology, which comes under the State Council of the PRC.

This is especially problematic for the Philippines given its ongoing territorial dispute with China over portions of the West Philippine Sea, the study found.

For more information:

France L. Castro
House of Representatives, Quezon City, Philippines
Rm. SW-511
Phone: (632) 8931-5001, Local: 7289
Direct: 8931-6193

Cinturion Participates at Expo 2020 Dubai UAE

HAMILTON, Bermuda, Dec. 16, 2021 (GLOBE NEWSWIRE) — Cinturion Corp Ltd. a global provider of scalable, subsea and terrestrial capacity-based network solutions spanning India, the Middle East and Europe, is excited to announce their participation at Expo 2020 Dubai, the largest event ever staged in the Middle East. Expo 2020 brings together over 200 participants from around the world with the common goal of supporting advancements in education, technology, and innovations that will shape the future and unlock new opportunities.

On January 13, 2022, Cinturion along with their partner GCCIA (Gulf Cooperation Council Interconnection Authority) will participate in a panel discussion session on the topics of global communications networks, the latest communications technologies, and the investment opportunities offered by GCCIA.

GCCIA along with other Telcom specialists will address:

  • The evaluation of connectivity in MENA region over the past years.
  • The potential of terrestrial cable in GCC and the opportunities it brings for the Hyperscale’s / Cloud companies as well as large enterprises.
  • The challenges in communication technologies for long terrestrial cable and how to overcome the challenge.

Cinturion will have the opportunity to reveal their TEAS – Trans Europe Asia System. The most advanced new-build network that will fulfill demand for an open-access system with the lowest latency and most diverse routes between India, the Middle East & Europe. TEAS will provide much needed capacity, speed, and redundancy to companies in the region, particularly new data centers as well as content and cloud service providers.

TEAS network consists of two diverse connections across the Mediterranean Sea, continuing with two diverse paths inter-linking the Middle East, with multiple routes across the Arabian Peninsula, and a route through the Gulf of Aqaba and the Red Sea. This first new dual path (subsea and terrestrial) system of its kind will provide geographic routes between Pescara, Italy and Marseille, France and Mumbai, India. TEAS will enable new services with its unique and robust optical capabilities to support modern Data Center deployments, bringing broadband and ultra-low latency access to European, Middle East and Indian markets. When complete, TEAS will offer individual fiber ownership and open a new passage for internet traffic to a broad range of customers.

For information on GCCIA contact Alaa Rahma, Email:
Go to for further information.

For Cinturion and TEAS sales contact Bill Marra, Media contact Lisa Cruise,

Fraser Institute News Release: 83% of world’s population live in countries where freedom declined

TORONTO, Dec. 16, 2021 (GLOBE NEWSWIRE) — Even before COVID—and the response from governments worldwide—global freedom was on the wane, finds a study released today by Canada’s Fraser Institute and the U.S.-based Cato Institute.

“When people are free, they have more opportunity to prosper and pursue happier healthier lives for themselves and their families,” said Fred McMahon, resident fellow at the Fraser Institute and co-author of this year’s Human Freedom Index. The index covers the period from 2008, the earliest year of comprehensive data, to 2019, the most recent year of comprehensive data.

The index measures personal freedom— the rule of law, safety and security, identity and relationships (i.e. the freedom to choose your relationship partner), freedom of movement, speech, assembly and religion—alongside economic freedom, the ability of individuals to make their own economic decisions.

From 2008 to 2019, 83 per cent of the world’s population experienced a decline in freedom.

“These data are pre-COVID so the percentage will likely increase in future reports and the country rankings will likely also see significant variance,” McMahon said.

Switzerland tops this year’s freedom index followed by New Zealand, Denmark, Estonia and Ireland (Canada tied with Finland for sixth place). The five least-free countries are (in descending order) Egypt, Sudan, Yemen, Venezuela and Syria.

Overall worldwide rankings for other significant countries include the United Kingdom (14), Germany, Japan and the United States (tied at 15), Taiwan (19), Chile (28), Hong Kong (30), Brazil (78), Mexico (93), India (119), Nigeria (123), Russia (126), Turkey (139), China (150), Saudi Arabia (155) and Iran (160).

Regionally, North America (Canada and the United States), Western Europe and Oceania have the highest levels of freedom while the Middle East and North Africa, sub-Saharan Africa and South Asia have the lowest levels.

Crucially, people in freer countries are more prosperous than those in less-free countries. For example, the average per-capita income for the top-quartile countries on the index was US$48,748 compared to US$11,259 for the least-free quartile in 2019.

“When government limits the ability of people to move, assemble and speak freely, people are less able to lead the lives they want to live,” said Ian Vásquez, report co-author and Cato Institute Vice President for International Studies.

Ryan Murphy, Research Associate Professor Southern Methodist University, and Guillermina Sutter Schneider, data scientist and project manager at Cato Institute, are co-authors. The complete index, a joint project of the Fraser Institute and the Cato Institute, is available as a free PDF download at

The 10 freest and the least-free countries in 2019:

The 10 freest jurisdictions The 10 least-free countries
1. Switzerland 156. Libya
2. New Zealand 157. Iraq
3. Denmark 157. Burundi
4. Estonia 159. Somalia
5. Ireland 160. Iran
6. Finland (tied) 161. Egypt
6. Canada (tied) 162. Sudan
8. Australia 163. Yemen
9. Sweden 164. Venezuela
10. Luxembourg 165. Syria

Fred McMahon, Dr. Michael A. Walker Research Chair in Economic Freedom
Fraser Institute

To arrange media interviews or for more information, please contact:
Mark Hasiuk, Fraser Institute
(604) 688-0221 ext. 517

Follow the Fraser Institute on Twitter and Facebook

The Fraser Institute is an independent Canadian public policy research and educational organization with offices in Vancouver, Calgary, Toronto, Montreal and Halifax and ties to a global network of think-tanks in 87 countries. Its mission is to improve the quality of life for Canadians, their families and future generations by studying, measuring and broadly communicating the effects of government policies, entrepreneurship and choice on their well-being. To protect the Institute’s independence, it does not accept grants from governments or contracts for research. Visit

InnoSkel awarded Innovation Passport by the UK MHRA for the treatment of a rare bone disorder

InnoSkel awarded Innovation Passport by the UK MHRA for the treatment of a rare bone disorder

First step in the recent UK MHRA initiative to accelerate the development and access to innovative medicines in the UK

Designation recognizes the potential of InnoSkel’s lead program for pediatric patients with spondyloepiphyseal dysplasia congenita (SEDc)

Nice, France, 16 December 2021 InnoSkel (the “Company”), a pioneering biotechnology company developing transformative therapies for the unmet needs of individuals with rare bone disorders, today announced that it has been awarded an Innovation Passport under the UK Medicines and Healthcare products Regulatory Agency’s (MHRA) Innovative Licensing and Access Pathway (ILAP), to pursue accelerated patient access for its first-in-class treatment for spondyloepiphyseal dysplasia congenita (SEDc), a type II collagen disorder.

INS-101, InnoSkel’s lead gene therapy program, is being developed for the treatment of SEDc in pediatric patients, for whom there is currently no disease-modifying therapy available. SEDc is a rare genetic bone disorder that is present from birth and is associated with skeletal deformities that worsen with age, some of which can be life-threatening requiring repeat surgical procedures. Patients with SEDc also experience a number of other severe complications, including irregular bone growth, respiratory insufficiency, joint pain, hip and spine deformities and early onset of osteoarthritis. INS-101 is designed to be administered by a systemic delivery route to restore COL2A1 function in growth plates, making it an ideal candidate to treat SEDc. INS-101 has demonstrated strong efficacy in a mouse model, showing restoration of bone growth and prevention of disease complications.

Elvire Gouze, PhD, Founder and Chief Executive Officer of InnoSkel, said: “The Innovation Passport designation by the UK MHRA is an important milestone for InnoSkel and the SEDc community and will enable us to accelerate the development of a treatment for this rare and debilitating bone disorder. The passport provides the opportunity to engage with regulators, health technology assessment (HTA) bodies and other partners at a pre-clinical stage with the endorsement of an acceptable risk assessment. In addition, the target development profile (TDP) will assist the company with the clinical trial design and evidence generation with the aim of achieving early access in the UK.

The MHRA’s ILAP was launched at the start of 2021 and aims to accelerate the time to market, facilitating safe, early and financially sustainable patient access to medicines. The pathway features enhanced input and interactions with the MHRA and other stakeholders including the National Institute for Health and Care Excellence (NICE), and the Scottish Medicines Consortium (SMC). The decision to award the Innovation Passport to InnoSkel’s INS-101 program was made by the ILAP Steering Group, which is comprised of representatives from MHRA, NICE, and SMC.

To receive an Innovation Passport, INS-101 met the following criteria: (1) the condition is life-threatening or seriously debilitating; (2) the program is intended for a rare disease or special population; and (3) the medicine has the potential to offer benefits to patients.

The Innovation Passport designation is the first step in the ILAP process and triggers the MHRA and its partner agencies to create a target development profile to chart out a roadmap for regulatory and development milestones with the goal of early patient access in the UK. Other benefits of ILAP include a 150-day accelerated assessment, rolling review and a continuous benefit risk assessment.

About SEDc

SEDc is a rare disease with a prevalence of 1 in 50,000. It is the most common severe type II collagen disorder, resulting from mutations in the COL2A1 gene, which prevents bones and other connective tissues from developing properly. Clinical features of type II collagen disorders show a wide range of severity and complexity. SEDc typically presents with severe disproportionate short stature with high risk of cervical instability, spinal cord damage, hip joint deformity, locomotor difficulties, respiratory insufficiency, ocular manifestations, orofacial features and premature osteoarthritis.

About InnoSkel

InnoSkel is a pioneering platform biotechnology company developing transformative therapies for the unmet needs of individuals with rare bone disorders. Initially the Company is developing a gene therapy for a group of diseases known as type II collagen disorders, whilst also expanding the use of its technology and know-how to target and treat other rare bone conditions. InnoSkel’s lead asset, INS-101, is a gene therapy for type II collagen disorders which has demonstrated good efficacy in proof-of-concept studies. The Company’s goal is to make a meaningful difference to the lives of underserved patient populations suffering from debilitating bone disorders.  InnoSkel’s labs are in Sophia Antipolis Biotechnology Park in Nice, France.

For more information, visit

For more information please contact:


Elvire Gouze, Founder and CEO

Consilium Strategic Communications

Mary-Jane Elliott / Melissa Gardiner / Allison Connolly

Tel: +44 (0) 20 3709 5700

FourKites Closes a Record-breaking 2021 at the Forefront of Supply Chain Visibility in Asia-Pacific

Tracking 2.5 million shipments daily and touching 50% of the Fortune 500, market pioneer achieves record growth in APAC and sets unprecedented pace of community-driven innovation

FourKites Closes a Record-breaking 2021 at the Forefront of Supply Chain Visibility in Asia-Pacific

Tracking 2.5 million shipments daily and touching 50% of the Fortune 500, market pioneer achieves record growth in APAC and sets unprecedented pace of community-driven innovation

CHENNAI, India, Dec. 15, 2021 (GLOBE NEWSWIRE) — FourKites®, the world’s leading real-time supply chain visibility platform, today announced a year of record growth as the company executed on its vision to optimize global supply chains with real-time visibility data and machine learning.

Globally, the company saw triple-digit growth in total shipments; drove 95% growth in new APAC customers and 50% total growth in new customers globally – including Barilla Group, Beyond Meat, Cardinal Health, Haworth, LyondellBasell, McCain Foods, Roehm, Rove Concepts and Yamaha Motors; significantly expanded its carrier network; and extended real-time visibility to more than 2,800 ports and 2.5 million facilities worldwide.

Key to its growth in 2021 was FourKites’ significant expansion in APAC, with notable year-over-year increases in total loads, ports and facilities tracked. Additionally, the company made critical executive appointments and expanded its employee base on the heels of a $100 million financing round. Specifically, in 2021 FourKites APAC saw:

  • 120% growth in loads year-over-year, with over 112 billion miles tracked and over 5 billion estimated times of arrival computed globally
  • 50% growth of its APAC carrier network
  • 2X growth in monthly intermodal volume, with over-the-road, ocean, rail and barge tracking capabilities across 42 countries in the region
  • 4X growth in monthly ocean volume, and now tracking 98% of global ocean traffic
  • 91% growth in the number of ports tracked per month
  • 89% growth in the number of facilities tracked per month, with nearly 8,000 facilities tracked in APAC

Alleviating disruptions with innovative solutions for every mode
FourKites’ local teams and industry expertise in APAC have helped the company address critical use cases in the region, including the ability to track cross-border shipments and the temperature of freight. And amid another year of constant disruptions, FourKites doubled-down on its customer-driven innovation model, with more than 65 new features resulting from customer feedback. These industry-first capabilities help FourKites users track shipments end-to-end across all modes and geographies, from sourcing to manufacturing to final destination.

These innovations included the patented Smart Forecasted Arrival (SFA) that provides frequent and highly accurate ETAs even for untrackable freight in transit. This feature is especially valuable in APAC, where connectivity is inconsistent as drivers pass through certain regions, or as trucks do not have the technology to provide location data. The company also announced Dynamic ETA® for Ocean; Dynamic ETA® for Air; a major upgrade to Dynamic YardSM; its new Order Intelligence Hub (OIH), which provides a single-pane-of-glass view of the entire lifecycle of every order; and powerful new collaboration features – including Instant Messaging, an updated CarrierLink mobile app for drivers, and enhancements to Partner Hub, its self-service, secure GPS onboarding solution for brokers and carriers.

Forging powerful new partnerships to accelerate end-to-end visibility
In 2021, FourKites forged new strategic partnerships with global supply chain and technology leaders as it continues to execute on its bold vision for the future of digital supply chains, where automated, interconnected and collaborative supply chains are optimized by real-time visibility data and machine learning.

New partnerships in 2021 include a global partnership with Zebra Technologies Corporation (NASDAQ: ZBRA), in which Zebra is now reselling FourKites’ Dynamic Yard and real-time visibility platform as part of its suite of asset visibility solutions. Additionally, Zebra’s MotionWorks Yard solution has been integrated with FourKites Dynamic Yard and Zebra locationing hardware and professional services to increase the in-yard and over-the-road capabilities of their customers. In addition, FourKites announced an alliance with Infosys to accelerate the delivery of best-in-class supply chain process innovations and technology solutions.

“It’s been another year of tremendous challenges, but also extraordinary collaboration and progress as a supply chain community,” said FourKites founder and CEO Mathew Elenjickal. “I’m particularly proud of our momentum in the APAC region, where we are now tracking loads in 42 countries. There is a great deal more to come in 2022 as we continue to invest in the region with new talent, solutions and partnerships.”

In 2021, FourKites’ market leadership was recognized via several prestigious industry awards and reports; including being named a leader in the 2021 Gartner Magic Quadrant for Real-Time Transportation Visibility Platforms; #1 supply chain visibility software provider in G2’s Winter Grid® based on overall Market Presence; the sole supply chain company named an AI Trailblazer by Everest Group; and recognition as a Great Place to Work® by the Great Place to Work (GPTW) Institute for the third consecutive year.

Customers in their own words
“I’ve engaged with the FourKites team and they have a fundamental, deep interest in the problems that we have. It’s tough to find that. Your business is dynamic, you need a partner that’s dynamic too.” — Tom France, Vice President, Global Distribution, Logistics and Transportation, Trane Technologies

“FourKites’ Live Network Congestion Map is a great way to understand current impacts and potential risks for the global supply networks that rely on ocean freight. We are grateful to FourKites for their responsiveness and for providing this visibility so quickly.” — Sergiy Yablonskiy, Senior Product Manager for Transportation at Nestlé.

“With FourKites, we have all the information we need in one single reliable source, in real time. Knowing the variations of ETAs in real time allows us to better manage our inventories – even reducing the percentage of safety stock of some raw materials so we can change to plan for just-in-time production. This connection that exists between planning and reliable transit times allows us to be prepared for any change in volume, either up or down, and – above all – to attend to the urgency that we may have in production changes.” — Fernanda Ongay, Transportation Manager, Constellation Brands

About FourKites
FourKites® is the #1 supply chain visibility platform in the world, extending visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2.5 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching 176 countries, FourKites combines real-time data and powerful machine learning to help companies digitize their end-to-end supply chains. More than 750 of the world’s most recognized brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit

Media Contact:
Marianna Vyridi
Big Valley Marketing for FourKites
+1 (650) 468-3263

Nikkiso Clean Energy & Industrial Gases Group เป็นสมาชิกประเภทตัวแทนของ California Fuel Cell Partnership

เตเมคูลา รัฐแคลิฟอร์เนีย วันที่, Dec. 16, 2021 (GLOBE NEWSWIRE) — Nikkiso Clean Energy & Industrial Gases Group (กลุ่มบริษัท) ซึ่งเป็นบริษัทในเครือของ Nikkiso Co., Ltd (Japan) มีความภูมิใจที่จะประกาศว่าทางกลุ่มบริษัทได้เข้าร่วมกับ California Fuel Cell Partnership (CaFCP) ในฐานะตัวแทน

สมาคมดังกล่าวกำลังผลักดันให้มีการจัดตั้งสถานีเติมเชื้อเพลิงไฮโดรเจน 200 แห่งภายในปี 2025 เพื่ออนาคตที่ยั่งยืน โดยช่วยให้รถยนต์ รถบรรทุก และรถโดยสารปล่อยมีการปล่อยมลพิษเป็นศูนย์ การร่วมเป็นสมาชิกของ CaFCP เป็นส่วนหนึ่งของความมุ่งมั่นของกลุ่มบริษัทในการเป็นผู้นำด้านการเปลี่ยนแปลงไปสู่โลกที่ผู้คนมีสุขภาพดีขึ้น นอกจากนี้ ทางกลุ่มบริษัทยังได้ขยายการดำเนินธุรกิจทั่วโลก โดยเปิดศูนย์วิศวกรรมและบริการแห่งใหม่ในฮูสตันและเกาหลีในปีนี้ และศูนย์แห่งใหม่ในเยอรมนีในปี 2022

Peter Wagner ประธานกรรมการบริหารของ Nikkiso Clean Energy & Industrial Gases Group กล่าวว่า “เรารู้สึกตื่นเต้นที่ได้เป็นส่วนหนึ่งของ CaFCP ในการจัดหาทางเลือกเพื่อพลังงานสะอาด และหวังว่าจะได้ร่วมมือกับสมาชิกรายอื่น ๆ ของ CaFCP ในตลาดเชื้อเพลิงไฮโดรเจนเซลล์เชื้อเพลิงต่อไป”

ขณะนี้กำลังมีการพัฒนาผลิตภัณฑ์ไฮโดรเจนใหม่ ๆ หลายประเภท เช่น ปั๊มเติมเชื้อเพลิงไฮโดรเจนแบบเคลื่อนที่เครื่องแรก ปั๊มไฮโดรเจนแบบลูกสูบความจุสูง / แรงดันสูง และสถานีเติมเชื้อเพลิงไฮโดรเจนเหลวแบบบรรจุในภาชนะ นอกเหนือจากความสามารถในการให้บริการด้านวิศวกรรม การจัดซื้อ และโครงการจ้างเหมาแบบเบ็ดเสร็จเต็มรูปแบบ

บริษัทสมาชิก Cryogenic Industries, Inc. (ปัจจุบันเป็นสมาชิกของ Nikkiso Co., Ltd.) ผลิตอุปกรณ์แปรรูปก๊าซไครโอเจนทางวิศวกรรมและโรงงานขนาดเล็กสำหรับแปรรูปก๊าซธรรมชาติเหลว (LNG) บริการจัดการหลุมปิโตรเลียมหลังการขุดเจาะ และอุตสาหกรรมก๊าซสำหรับอุตสาหกรรม Cryogenic Industries ก่อตั้งขึ้นเมื่อ 50 ปีที่แล้ว โดยเป็นบริษัทแม่ของ ACD, Cosmodyne และ Cryoquip และเป็นกลุ่มที่ควบคุมโดยทั่วไปซึ่งมีหน่วยงานปฏิบัติการประมาณ 20 แห่ง

หากต้องการข้อมูลเพิ่มเติม โปรดเข้าไปที่ และ

Anna Quigley

Hyris Fully Embraces the Immunology Sector to Better Fight COVID-19 and Beyond, Presenting Its New, Disruptive T-Cell Test to the International Conference ‘A-Wish’

Hyris is going to present its new test to detect the body’s T Cell immune response to SARS-CoV-2 on 17 December 2021, at “A-WISH”, Alicante-Winter Immunology Symposium in Health, which will address strategies for the COVID-19 response and the development of the vaccines against SARS-CoV-2. This new solution leverages the Hyris System™, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform.

Hyris presents its disruptive T-Cells test to detect the body’s immune response to SARS-CoV-2.

Hyris presents its disruptive T-Cells test to detect the body’s immune response to SARS-CoV-2.

LONDON, Dec. 15, 2021 (GLOBE NEWSWIRE) — As the COVID-19 pandemic keeps causing concerns, with new variants spreading worldwide, it is now widely recognized that we must move beyond a “test&trace” only approach. World leaders and health institutions today aim to achieve high immunity rates among the population, facing the unprecedented challenge of a worldwide vaccination campaign against an emerging virus, for which no vaccine existed until a year ago.

Alongside with our genetic tests to detect SARS-CoV-2 anywhere, and at any time, we knew that we had to put our knowledge at the service of vaccination campaigns even further, leveraging the versatility of our AI platform to deliver a new kind of immunology test.So says Stefano Lo Priore, Founder and CEO at Hyris, a global biotech company renowned for its innovative and inclusive approach to genetic analysis. Hyris offers a wide range of solutions to support the fight against COVID-19 worldwide. Several Medical professionals and decision-makers have already made use of the Hyris SystemTM to reliably detect the presence of all the main Variants of Concern.

As a key part of a long-term strategy to fight COVID-19, Hyris keeps supporting Immunology Research, now presenting its new test to detect the body’s T Cell immune response to SARS-CoV-2 on 17 December 2021, at “A-WISH”, Alicante-Winter Immunology Symposium in Health. Organized by the Spanish Society of Immunology (SEI) and the University of Alicante (UA), the “A-WISH” Symposium promotes the advancement of the study of immunology, infectious diseases and vaccinology as well as Life and Health Sciences. This first edition specifically aims to address strategies for the COVID-19 response and pandemic preparedness, the development of the vaccines against SARS-CoV-2 and the immunological response to infection and different COVID-19 vaccines.

Until now, antibody testing has been considered the only tool to measure immunity to SARS-CoV-2,” explains Isabella Della Noce, Chief Biologist at Hyris,but individuals exposed to the virus or vaccinated do not necessarily develop or maintain antibody positivity. That is why we need to focus on T-Cells as they act together with antibodies to prevent pathogen spread and remove virus-infected cells. An individual negative to an antibody test could still be immune, thanks to responsive T-Cells. Therefore, measuring T-Cells response is a new disruptive approach to fight SARS-CoV-2.”

The new Hyris T-Cells clinical Test was developed through exclusive agreements between Hyris and some illustrious healthcare scientific organizations, such as with Singapore Duke-NUS Medical School and New York Ichan School of Medicine at Mount Sinai, both well renowned worldwide for their publications and studies within the immunology and virology fields.

“This new test enables quick evaluation of T-cell immune responses in COVID-19 convalescent patients as well as vaccinated people, also indicating where patients are responsive due to vaccination, virus exposure or both,” specifies Lorenzo Colombo, Global Chief Technical Officer at Hyris. “And that’s where PCR testing comes into the picture. Not only data show that PCR is fully comparable in accuracy and sensitivity with other assays traditionally used to measure the body’s immune response, but it is more convenient and faster as a widely used diagnostic technology. This is indeed a new dimension for vaccine strategies.”

This new test workflow has been already adopted by international research projects and committees, such as VACCELERATE, the European Program for the acceleration of phase 2 & 3 COVID-19 vaccine trials and the creation of a pan-European platform for clinical trial design and conduct, and the Spanish governmental Project Ene-Covid, the “Estudio Nacional de sero-Epidemiología de la Infección por SARS-CoV-2 en España“.

To support and validate vaccination campaigns worldwide, we need much greater access to accurate tests, especially in the Immunology field,” concludes Lo Priore. “This disruptive approach can also be applied to other immunology areas, such as oncology or related to even more specific human pathogens. It can also focus strategically on specific patients’ categories, such as, for example, immune-compromised, transplanted or cancer patients. Our immune system really is the perfect “source-code” to our knowledge, about how to take care of life.”

The 2021 “A-WISH” Symposium will bring together a group of internationally recognized immunologists, microbiologists, molecular biologists, epidemiologists, virologists and professionals from a wide range of disciplines in the biomedical field to present and discuss the most recent results of top-tier immunology scientific research and innovations. Hyris will participate in the discussion, aiming to accelerate the development of new approaches to disease prevention.

Contact a Hyris expert to discover how to perform beyond your current diagnostic capability, at

Related Images

Image 1: Hyris presents its disruptive T-Cells test to detect the body’s immune response to SARS-CoV-2.

A doctor holding a tablet showing the HYRIS bAPP™

This content was issued through the press release distribution service at


TouchRetouch Gets Brand-New Features, Smarter Technologies, and Fresh Design

TouchRetouch 5.0 is bringing new powerful features covering such challenging object removal cases as editing out things that are close to other objects, eliminating meshes blocking nice views, and a few more great additions giving a smooth and pleasing retouching experience.

Object-Aware Touch-Ups

Object-Aware Touch-Ups

BERLIN, Dec. 15, 2021 (GLOBE NEWSWIRE) —  ADVA Soft has announced the long-awaited 5.0 update of its TouchRetouch object remover beloved by many photography lovers. The update offers new helpful tools for dealing with such challenging cases as editing out objects that are close to other objects and eliminating meshes from photos. The app now also offers a smoother 360° photo editing experience, new options for more flexible line removal, more appealing interface, and many more enhancements.

The team has done a great deal of work on the way to making the app even more efficient in terms of saving users’ time and making the interaction with the app more harmonious and pleasant.

Object-Aware Retouching

The new algorithm allows solving complex content removal cases where two objects are adjacent and you want to remove one of them — it will erase an undesired item while leaving a clean finish near the edges. The smart blending technology implemented in the algorithm will mix the pixels properly so that no smears are produced.

Flexible Line Removal

With the new Auto & Manual modes as well as the selection control points in the Lines tool, it’s now possible to adjust the shape and thickness of linear objects with more precision.

Mesh Removal Like Magic

The app’s brand-new mesh detection and removal algorithm is capable of automatically finding, selecting, and eliminating meshes from images in almost no time. No need to routinely mark each line in a mesh. Pure magic!

Other Cool New Stuff

• Restore/Reapply brushes: With the newly added Restore and Reapply features, you can bring lost pixels back when needed and re-add the same changes to a photo.

• New source modes in Clone Stamp: The source pointer can be locked in one place so that it doesn’t move around, or it can be set to slide back to its initial position, thus making it easier to clone textures.

• Smoother 360° photo editing: Navigation around a spherical panorama is more enjoyable now; no need to leave the 360° View to move to another part of a photo or switch to another menu or tool.

• Resize option: Now it’s possible to downsize images to the desired dimensions.

• Interface improvements: It’s possible to choose among the Light, Dark, and System appearances as well as experiment with different app icon looks. Users can also feel more comfortable when selecting photos with a few new gallery views.

Pricing and Availability

TouchRetouch 5.0 will be available for $3.99 and will require Apple devices running iOS and iPadOS 13.0 or later.

About ADVA Soft: We are a team of like-minded professionals and enthusiastic innovators committed to designing smart yet simple apps aimed at creating magic in our users’ photos. At ADVA Soft, we are constantly experimenting with new ideas and developing new technologies to improve our products both functionally and visually. We pay much attention to UX and polish each and every UI element to make the interaction with it as comfortable as possible, because we believe that if a user has a great experience with the app, it brings positive emotions to him (her) and makes him (her) happy. And if a user is happy, we are happy too.

Press Contact

Kostyantyn Svarychevskyy

Related Files



Related Images

Image 1: Object-Aware Touch-Ups

Smart editing at edges.

This content was issued through the press release distribution service at